Variables determining mortality in patients with Acinetobacter baumannii meningitis/ventriculitis treated with intrathecal colistin

Clinical Neurology and Neurosurgery

Volumn 153, Issue , 2017, Pages 43-49

  Ceylan, Bahadır ^a   Arslan, Ferhat ^b   Sipahi, Oguz Resat ^c   Sunbul, Mustafa ^d   Ormen, Bahar ^e   Hakyemez, İsmail N ^f   Turunc, Tuba ^g   Yıldız, Yeşim ^h   Karsen, Hasan ⁱ   Karagoz, Gul ^j   Tekin, Recep ^k   Hizarci, Burcu ^a   Turhan, Vedat ^l   Senol, Sebnem ^m   Oztoprak, Nefise ⁿ   Yılmaz, Mesut ^a   Ozdemir, Kevser ^o   Mermer, Sinan ^c   Kokoglu, Omer F ^p   Mert, Ali ^a  

^a ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

^b ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e Atatürk Educational and Research Hospital   (Turkey)

^f Bezmi Alem University   (Turkey)

^g BASKENT UNIVERSITY   (Turkey)

^h GAZI UNIVERSITY   (Turkey)

ⁱ HARRAN UNIVERSITY   (Turkey)

^j Umraniye Training and Research Hospital   (Turkey)

^k DICLE UNIVERSITY   (Turkey)

^l GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^m CELAL BAYAR UNIVERSITY   (Turkey)

ⁿ Antalya Education and Training Hospital   (Turkey)

^o PAMUKKALE UNIVERSITY   (Turkey)

^p KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

more..

Author keywords

Acinetobacter baumannii; Colistin; Intratechal; Meningitis

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULBACTAM; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BRAIN VENTRICULITIS; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NONHUMAN; RETROSPECTIVE STUDY; YOUNG ADULT; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CEREBRAL VENTRICULITIS; CLINICAL TRIAL; INTRASPINAL DRUG ADMINISTRATION; MENINGITIS, BACTERIAL; OUTCOME ASSESSMENT; PATHOGENICITY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CEREBRAL VENTRICULITIS; COLISTIN; FEMALE; HUMANS; INJECTIONS, SPINAL; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; THIENAMYCINS; YOUNG ADULT;

EID: 85007240653     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2016.12.006     Document Type: Article

References (30)

1. [1] Giamarellou, H., Antoniadou, A., Kanellakopoulou, K., Acinetobacter baumannii: a universal threat to public health?. Int. J. Antimicrob. Agents 32:August (2) (2008), 106–119.
2. [2] Navon-Venezia, S., Ben-Ami, R., Carmeli, Y., Update on Pseudomonas aeruginosa and A. baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18:August (4) (2005), 306–313.
3. [3] Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet., 2(January (1)), 2006, e7.
4. [4] Giamarellou, H., Poulakou, G., Multidrug-resistant Gram-negative infections: what are the treatment options?. Drugs 69:Octobert (14) (2009), 1879–1901.
5. [5] Markantonis, S.L., Markou, N., Fousteri, M., Sakellaridis, N., Karatzas, S., Alamanos, I., et al. Penetration of colistin into cerebrospinal fluid. Antimicrob. Agents Chemother. 53:November (11) (2009), 4907–4910.
6. [6] Antachopoulos, C., Karvanen, M., Iosifidis, E., Jansson, B., Plachouras, D., Cars, O., et al. Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob. Agents Chemother. 54:September (9) (2010), 3985–3987.
7. [7] Fotakopoulos, G., Makris, D., Chatzi, M., Tsimitrea, E., Zakynthinos, E., Fountas, K., Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir. (Wien) 158:March (3) (2016), 603–610 discussion 610.
8. [8] Khawcharoenporn, T., Apisarnthanarak, A., Mundy, L.M., Intrathecal colistin for drug-resistant A. baumannii central nervous system infection: a case series and systematic review. Clin. Microbiol. Infect. 16:July (7) (2010), 888–894.
9. [9] Lee, C.-H., Tang, Y.-F., Su, L.-H., Chien, C.-C., Liu, J.-W., Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb. Drug Resist. 14:September (3) (2008), 233–237.
10. [10] Ng, J., Gosbell, I.B., Kelly, J.A., Boyle, M.J., Ferguson, J.K., Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J. Antimicrob. Chemother. 58:November (5) (2006), 1078–1081.
11. [11] Al Shirawi, N., Memish, Z.A., Cherfan, A., Al Shimemeri, A., Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. J. Chemother. (Florence Italy) 18:October (5) (2006), 554–558.
12. [12] Paramythiotou, E., Karakitsos, D., Aggelopoulou, H., Sioutos, P., Samonis, G., Karabinis, A., Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med. Mal Infect. 37:February (2) (2007), 124–125.
13. [13] Cascio, A., Conti, A., Sinardi, L., Iaria, C., Angileri, F.F., Stassi, G., et al. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int. J. Infect. Dis. 14:July (7) (2010), e572–e579.
14. [14] Hoenigl, M., Drescher, M., Feierl, G., Valentin, T., Zarfel, G., Seeber, K., et al. Successful management of nosocomial ventriculitis and meningitis caused by extensively drug-resistant Ainetobacter baumannii in Austria. Can. J. Infect. Dis. Med. Microbiol. 24:3 (2013), e88–90.
15. [15] Karaiskos, I., Galani, L., Baziaka, F., Katsouda, E., Ioannidis, I., Andreou, A., et al. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int. J. Antimicrob. Agents 41:May (5) (2013), 480–483.
16. [16] Dersch, R., Robinson, E., Beume, L., Rauer, S., Niesen, W.-D., Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria. Neurol. Sci. 36:April (4) (2015), 633–634.
17. [17] López-Alvarez, B., Martín-Láez, R., Fariñas, M.C., Paternina-Vidal, B., García-Palomo, J.D., Vázquez-Barquero, A., Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir. (Wien) 151:Nov (11) (2009), 1465–1472.
18. [18] Lozier, A.P., Sciacca, R.R., Romagnoli, M.F., Connolly, E.S., Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 62:February (Suppl. 2) (2008), 688–700.
19. [19] Magiorakos, A.-P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:March (3) (2012), 268–281.
20. [20] Tängdén, T., Enblad, P., Ullberg, M., Sjölin, J., Neurosurgical Gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin. Infect. Dis. 52:June (11) (2011), 1310–1316.
21. [21] Maragakis, L.L., Perl, T.M., Acinetobacter baumannii epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:April (8) (2008), 1254–1263.
22. [22] López-Alvarez, B., Martín-Láez, R., Fariñas, M.C., Paternina-Vidal, B., García-Palomo, J.D., Vázquez-Barquero, A., Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricularcolistin. Acta Neurochir. (Wien) 151:November (11) (2009), 1465–1472.
23. [23] De Bonis, P., Lofrese, G., Scoppettuolo, G., Spanu, T., Cultrera, R., Labonia, M., et al. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur. J. Neurol. 23:January (1) (2016), 68–75.
24. [24] Rodríguez Guardado, A., Blanco, A., Asensi, V., Pérez, F., Rial, J.C., Pintado, V., et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J. Antimicrob. Chemother. 61:April (4) (2008), 908–913.
25. [25] Falagas, M.E., Rafailidis, P.I., Kasiakou, S.K., Hatzopoulou, P., Michalopoulos, A., Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin. Microbiol. Infect. 12:December (12) (2006), 1227–1230.
26. [26] Kim, B.-N., Peleg, A.Y., Lodise, T.P., Lipman, J., Li, J., Nation, R., et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect. Dis. 9:April (4) (2009), 245–255.
27. [27] Giamarellos-Bourboulis, E.J., Xirouchaki, E., Giamarellou, H., Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 40:July (3) (2001), 117–120.
28. [28] Pantopoulou, A., Giamarellos-Bourboulis, E.J., Raftogannis, M., Tsaganos, T., Dontas, I., Koutoukas, P., et al. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. Int. J. Antimicrob. Agents 29:January (1) (2007), 51–55.
29. [29] Vila, J., Pachón, J., A. baumannii resistant to everything: what should we do?. Clin. Microbiol. Infect. 17:July (7) (2011), 955–956.
30. [30] Tunkel, A.R., Hartman, B.J., Kaplan, S.L., Kaufman, B.A., Roos, K.L., Scheld, W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 39:November (9) (2004), 1267–1284.